Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Discuss quality and patient safety issues with CMS staff.

Discuss Medicare SNF payments with MedPAC staff.

Discuss Medicare DSH funding with CMS staff.

Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff.

Discuss NYSDOH CHSLI construction waiver with HHS staff.

Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff.

Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support).

Discuss potential surprise billing legislation with Congressional staff and members.

Support a delay of the Medicaid DSH cuts.

Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN.


Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid.

Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.

Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff.

Discuss issues related to drug-resistant infections with Congressional staff.

Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff.

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office, Medicare Payment Advisory Commission (MedPAC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), Substance Abuse & Mental Health Services Administration (SAMHSA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act.

Support a delay of the Medicaid DSH cuts.

Discuss Medicare SNF payments with MedPAC staff.

Discuss Medicare DSH funding with CMS staff.

Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff.

Oppose cuts to the 340B program.

Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff.


Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members.

Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support).

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Oppose the hospital provisions in the White House's FY 2020 budget blueprint.

Oppose the inclusion of language that would limit HHS and its relevant subcontractors' ability to implement liver allocation reforms.

Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation.

Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes